GuidanceMHRA
Nitrosamines impurities in medicines
Guidance to help medicine manufacturers meet safe limits on levels of nitrosamine impurities in medicines.
First published: Aug 24, 2023Last updated: Aug 24, 2023Changes: 1
Latest change: First published.
The full document, source attachments, and change history are available on KeyPedia. Sign in to view.